INR 119.05
(2.23%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.41 Billion INR | -42.16% |
2022 | 2.45 Billion INR | 7.24% |
2021 | 2.28 Billion INR | 54.63% |
2020 | 1.47 Billion INR | 15.43% |
2019 | 1.28 Billion INR | 12.11% |
2018 | 1.14 Billion INR | 39.23% |
2017 | 821.28 Million INR | -7.62% |
2016 | 889.05 Million INR | -38.94% |
2015 | 1.45 Billion INR | 12.18% |
2014 | 1.29 Billion INR | 14.38% |
2013 | 1.13 Billion INR | 28.69% |
2012 | 881.76 Million INR | 105.95% |
2011 | 428.14 Million INR | 50.68% |
2010 | 284.13 Million INR | -6.85% |
2009 | 305.03 Million INR | 48.08% |
2008 | 205.99 Million INR | -2.77% |
2007 | 211.86 Million INR | 5.14% |
2006 | 201.5 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 376.33 Million INR | -24.43% |
2024 Q2 | 682.58 Million INR | -10.26% |
2023 Q2 | 641.64 Million INR | 12.43% |
2023 Q1 | 570.7 Million INR | -16.31% |
2023 Q4 | 498 Million INR | -19.01% |
2023 Q3 | 614.91 Million INR | -4.17% |
2023 FY | 1.41 Billion INR | -42.16% |
2022 Q2 | 567.1 Million INR | -4.18% |
2022 Q4 | 681.93 Million INR | 11.28% |
2022 Q3 | 612.81 Million INR | 8.06% |
2022 Q1 | 591.85 Million INR | 57.58% |
2022 FY | 2.45 Billion INR | 7.24% |
2021 FY | 2.28 Billion INR | 54.63% |
2021 Q2 | 649.17 Million INR | 26.99% |
2021 Q1 | 511.18 Million INR | 55.2% |
2021 Q4 | 375.58 Million INR | -50.11% |
2021 Q3 | 752.78 Million INR | 15.96% |
2020 Q3 | 382.6 Million INR | 11.57% |
2020 Q2 | 342.92 Million INR | -1.8% |
2020 Q4 | 329.37 Million INR | -13.91% |
2020 Q1 | 349.22 Million INR | 32.67% |
2020 FY | 1.47 Billion INR | 15.43% |
2019 Q1 | 333 Million INR | 83.1% |
2019 Q2 | 323.25 Million INR | -2.93% |
2019 Q3 | 363.39 Million INR | 12.42% |
2019 Q4 | 263.21 Million INR | -27.57% |
2019 FY | 1.28 Billion INR | 12.11% |
2018 Q2 | 327.81 Million INR | -20.92% |
2018 Q1 | 414.54 Million INR | -21.79% |
2018 FY | 1.14 Billion INR | 39.23% |
2018 Q4 | 181.86 Million INR | -43.1% |
2018 Q3 | 319.62 Million INR | -2.5% |
2017 Q1 | 527.71 Million INR | -44.42% |
2017 FY | 821.28 Million INR | -7.62% |
2017 Q4 | 530 Million INR | -29.58% |
2017 Q3 | 752.65 Million INR | 28.62% |
2017 Q2 | 585.16 Million INR | 10.89% |
2016 Q4 | 949.42 Million INR | 47.29% |
2016 Q3 | 644.6 Million INR | 17.4% |
2016 Q2 | 549.06 Million INR | 81.93% |
2016 Q1 | 301.79 Million INR | 72.28% |
2016 FY | 889.05 Million INR | -38.94% |
2015 Q3 | 683.66 Million INR | 51.32% |
2015 Q1 | 230.09 Million INR | 0.0% |
2015 Q4 | 175.17 Million INR | -74.38% |
2015 FY | 1.45 Billion INR | 12.18% |
2015 Q2 | 451.79 Million INR | 96.35% |
2014 FY | 1.29 Billion INR | 14.38% |
2013 FY | 1.13 Billion INR | 28.69% |
2012 Q2 | 99.14 Million INR | 86.42% |
2012 Q4 | 586 Million INR | 329.8% |
2012 FY | 881.76 Million INR | 105.95% |
2012 Q1 | 53.18 Million INR | 0.0% |
2012 Q3 | 136.34 Million INR | 37.52% |
2011 FY | 428.14 Million INR | 50.68% |
2010 FY | 284.13 Million INR | -6.85% |
2009 FY | 305.03 Million INR | 48.08% |
2008 FY | 205.99 Million INR | -2.77% |
2007 FY | 211.86 Million INR | 5.14% |
2006 FY | 201.5 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.08% |
NATCO Pharma Limited | 10.05 Billion INR | 85.89% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | -1.171% |
Syncom Formulations (India) Limited | 942.39 Million INR | -50.597% |
Achyut Healthcare Limited | 1.6 Million INR | -88105.221% |
Ajanta Pharma Limited | 30.46 Billion INR | 95.341% |
Alkem Laboratories Limited | 32.83 Billion INR | 95.678% |
Alpa Laboratories Limited | 156.14 Million INR | -808.901% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 91.057% |
AstraZeneca Pharma India Limited | 2.6 Billion INR | 45.423% |
Aurobindo Pharma Limited | 39.23 Billion INR | 96.383% |
Bajaj HealthCare Limited | 985.34 Million INR | -44.033% |
Brooks Laboratories Limited | 51.18 Million INR | -2673.001% |
Divi's Laboratories Limited | 14.17 Billion INR | 89.984% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 98.52% |
Eris Lifesciences Limited | 4.94 Billion INR | 71.288% |
FDC Limited | 5.34 Billion INR | 73.465% |
Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 97.899% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 87.808% |
Granules India Limited | 7.18 Billion INR | 80.24% |
Gufic Biosciences Limited | 1.07 Billion INR | -31.689% |
Hester Biosciences Limited | 908.84 Million INR | -56.158% |
Indoco Remedies Limited | 4.74 Billion INR | 70.114% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 33.187% |
Ipca Laboratories Limited | 13.91 Billion INR | 89.801% |
Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -83.502% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -2974.838% |
Lasa Supergenerics Limited | 291.17 Million INR | -387.414% |
Laurus Labs Limited | 3.01 Billion INR | 52.862% |
Lupin Limited | 95.67 Billion INR | 98.517% |
Mankind Pharma Limited | 23.15 Billion INR | 93.87% |
Medicamen Biotech Limited | 335.16 Million INR | -323.437% |
Medico Remedies Limited | 161.84 Million INR | -776.907% |
Megasoft Limited | 49.52 Million INR | -2765.494% |
Piramal Pharma Limited | 19.91 Billion INR | 92.873% |
RPG Life Sciences Limited | 1.63 Billion INR | 13.224% |
Sigachi Industries Limited | 579.88 Million INR | -144.741% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 53.873% |
Unichem Laboratories Limited | 6.72 Billion INR | 78.899% |
Wanbury Limited | 1.16 Billion INR | -22.249% |
Windlas Biotech Limited | 1 Billion INR | -41.004% |
ZIM Laboratories Limited | 1.01 Billion INR | -40.093% |
Zydus Lifesciences Limited | 43.17 Billion INR | 96.713% |
Procter & Gamble Health Limited | 2.99 Billion INR | 52.62% |
Amrutanjan Health Care Limited | 1.09 Billion INR | -29.139% |
Bal Pharma Limited | 389.89 Million INR | -264.006% |
Strides Pharma Science Limited | 9.16 Billion INR | 84.51% |
Venus Remedies Limited | 1.91 Billion INR | 25.939% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 53.837% |
Nectar Lifesciences Limited | 625.55 Million INR | -126.876% |
Shilpa Medicare Limited | 2.18 Billion INR | 34.916% |
Aarti Drugs Limited | 1.16 Billion INR | -21.563% |
IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -29.161% |
Suven Life Sciences Limited | 109.75 Million INR | -1193.141% |
Ind-Swift Limited | 946.56 Million INR | -49.934% |
Valiant Laboratories Limited | 36.28 Million INR | -3810.888% |
J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 83.139% |
Solara Active Pharma Sciences Limited | 4.57 Billion INR | 69.011% |
Themis Medicare Limited | 782.85 Million INR | -81.288% |
Hikal Limited | 2.48 Billion INR | 42.919% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 93.375% |
Sequent Scientific Limited | 2.9 Billion INR | 51.092% |
Novartis India Limited | 470.1 Million INR | -201.898% |
Wockhardt Limited | 6.4 Billion INR | 77.825% |
Jubilant Pharmova Limited | 14.45 Billion INR | 90.181% |
Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -8655.388% |
Neuland Laboratories Limited | 2.92 Billion INR | 51.558% |
Morepen Laboratories Limited | 1.98 Billion INR | 28.591% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -244.115% |
Mangalam Drugs & Organics Limited | 676.14 Million INR | -109.898% |